DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 74 filers reported holding DERMA SCIENCES INC in Q2 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $252,000 | -91.4% | 81,239 | -87.3% | 0.03% | -89.0% |
| Q4 2015 | $2,930,000 | -82.7% | 641,236 | -52.1% | 0.29% | -76.2% |
| Q1 2014 | $16,979,000 | -21.3% | 1,339,039 | -32.9% | 1.22% | -51.6% |
| Q4 2013 | $21,585,000 | -12.6% | 1,994,876 | 0.0% | 2.51% | -2.5% |
| Q3 2013 | $24,697,000 | -7.3% | 1,994,876 | 0.0% | 2.58% | -27.0% |
| Q2 2013 | $26,632,000 | – | 1,994,876 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |